CD20 blockers eye crowded rheumatology market.
George S
GS
Mack
D000911:Antibodies, Monoclonal / Q000191:economics* / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20 / Q000187:drug effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000191:economics; D015195:Drug Design; D004345:Drug Industry / Q000191:economics* / Q000639:trends; D006801:Humans; D040541:Marketing / Q000191:economics* / Q000639:trends; D012219:Rheumatology / Q000191:economics / Q000639:trends; D014481:United States
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018951:Antigens, CD20; C527517:ofatumumab